Reply to Egesta Lopci, Arturo Chiti, and Massimo Lazzeri's Letter to the Editor re: Laura Evangelista, Alberto Briganti, Stefano Fanti, et al. New Clinical Indications for 18F/11C-choline, New Tracers for Positron Emission Tomography and a Promising

scientific article published on 26 March 2016

Reply to Egesta Lopci, Arturo Chiti, and Massimo Lazzeri's Letter to the Editor re: Laura Evangelista, Alberto Briganti, Stefano Fanti, et al. New Clinical Indications for 18F/11C-choline, New Tracers for Positron Emission Tomography and a Promising is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.EURURO.2016.03.024
P698PubMed publication ID27025587

P50authorMaria PicchioQ38589511
Laura EvangelistaQ52983502
Stefano FantiQ60369734
P2093author name stringStefano Fanti
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectclinical indicationQ110971784
P304page(s)e114-e115
P577publication date2016-03-26
P1433published inEuropean UrologyQ15763991
P1476titleReply to Egesta Lopci, Arturo Chiti, and Massimo Lazzeri's Letter to the Editor re: Laura Evangelista, Alberto Briganti, Stefano Fanti, et al. New Clinical Indications for 18F/11C-choline, New Tracers for Positron Emission Tomography and a Promising
P478volume70

Reverse relations

Q38804450Impact of 68Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomycites workP2860

Search more.